The efficacy and safety of a quadrivalent live attenuated influenza nasal vaccine in Japanese children: A phase 3, randomized, placebo-controlled study
Open Access
- 2 July 2024
- journal article
- research article
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 31 (2) , 102460
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Complications of influenza in 272 adult and pediatric patients in a German university hospital during the seasonal epidemic 2017–2018Wiener Medizinische Wochenschrift, 2021
- Intranasal vaccination with influenza HA/GO-PEI nanoparticles provides immune protection against homo- and heterologous strainsProceedings of the National Academy of Sciences, 2021
- Efficacy and safety of a live attenuated influenza vaccine in Chinese healthy children aged 3–17 years in one study center of a randomized, double-blind, placebo-controlled phase 3 clinical trial, 2016/17 seasonVaccine, 2020
- Live Attenuated Cold-Adapted Influenza VaccinesCold Spring Harbor Perspectives in Medicine, 2020
- Who and when to vaccinate against influenzaInternational Journal of Infectious Diseases, 2020
- Viral Shedding in Recipients of Live Attenuated Influenza Vaccine in the 2016–2017 and 2017–2018 Influenza Seasons in the United KingdomClinical Infectious Diseases, 2019
- Effect of a Russian-backbone live-attenuated influenza vaccine with an updated pandemic H1N1 strain on shedding and immunogenicity among children in The Gambia: an open-label, observational, phase 4 studyThe Lancet Respiratory Medicine, 2019
- Inactivated influenza vaccine effectiveness and an analysis of repeated vaccination for children during the 2016/17 seasonVaccine, 2018
- H3N2 influenza viruses in humans: Viral mechanisms, evolution, and evaluationHuman Vaccines & Immunotherapeutics, 2018
- Immunological mechanisms of vaccinationNature Immunology, 2011